Year archive

NexgenRx Inc. — 2022 filings

All 22 regulatory filings released by NexgenRx Inc. (NXG) in 2022, sourced directly from the official regulator.

22 Filings

2022 Period

2022 filings (22)

Filing	Released	Lang
News release - English.pdf Regulatory Filings	2022-11-30	English
News release - English.pdf Regulatory Filings	2022-11-30	English
Interim MD&A - English.PDF Regulatory Filings	2022-11-29	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2022-11-29	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2022-11-29	English
Interim financial statements/report – English.PDF Regulatory Filings	2022-11-29	English
News release - English.pdf Regulatory Filings	2022-05-18	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2022-05-17	English
Interim MD&A - English.PDF Regulatory Filings	2022-05-17	English
Interim financial statements/report – English.PDF Regulatory Filings	2022-05-17	English
Certificate re dissemination to shareholders.pdf Regulatory Filings	2022-04-28	English
Management information circular - English.pdf Regulatory Filings	2022-04-27	English
Other.pdf Regulatory Filings	2022-04-27	English
Form of proxy - English.pdf Regulatory Filings	2022-04-27	English
Notice of meeting - English.pdf Regulatory Filings	2022-04-27	English
Notice of the meeting and record date - English.pdf Regulatory Filings	2022-04-06	English
News release - English.pdf Regulatory Filings	2022-03-26	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2022-03-25	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2022-03-25	English
Audited annual financial statements – English.PDF Regulatory Filings	2022-03-25	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2022-03-25	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2022-03-25	English